
Alteogen defends its technology as Halozyme sues MSD over Keytruda injectable
Alteogen is standing firm. Hours after Halozyme filed a lawsuit accusing MSD (Merck & Co. in the U.S. and Canada) of infringing multiple patents tied to its engineered hyaluronidase technology, the Korean biotech responded with a sharp rebuttal -- …